BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
glucose metabolic process
,
Obesity
,
Intestine
,
Laser capture microdissection
,
SIRT1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
immunosuppressed hosts
Summary
General Info
Curated Studies
Most Correlated Studies
Monocytes of allogeneic transplant (alloSCT) patients receiving high or low intensity conditioning
Livers from transplant recipients, rejected following immunosuppression (IS) withdrawal
De-differentiated liposarcoma xenographs treated with rapamycin and sorafenib
CD8+ T alloproliferative or non-alloproliferative fractions post lenalidomide treatment
Macrophages pretreated with calcineurin inhibitor FK506 and infected with Aspergillus fumigatus
Explore Curated Studies Results
Literature
Most Relevant Literature
Vaccination of immunocompromised patients.
Herpes zoster infection, vaccination and immunocompromised rheumatology patients.
Diarrhea in the immunocompromised patient.
Chagas disease in the immunosuppressed host.
Otomycosis in immunocompetent and immunocompromised patients: comparative study and literature revie…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Molecular Diagnosis and Prognosis of Severe Pulmonary Infection Immunosuppressed Hosts
Discontinuation or Continuation of Immunosuppressive Therapy in Participants With Chronic Graft Vers…
Evaluation of the Impact of Reduced Immunosuppression
Early Tapering of Immunosuppressive Agents to Immunomodulation to Improve Survival of AML Patients
Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ